SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Link Pharma Chem informs about newspaper publications

31 May 2022 Evaluate

Pursuant to the provisions of Regulation 47(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Link Pharma Chem has informed that it enclosed the copies of newspaper advertisements for the Extract of Audited Financial Results of the Company for the Quarter and Financial year ended 31st March 2022.

The above information is a part of company’s filings submitted to BSE.

Link Pharma Chem Share Price

29.49 1.49 (5.32%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3703.10
Tata Chemicals 709.05
SRF 2493.65
Pidilite Inds. 1393.25
Deepak Nitrite 1538.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×